|
Wockhardt's shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemotherapy. The drug is nearing Phase III trials for global approval.
Category:
News and Media
RITES' shares surged 4.2% after securing a Rs 297.67 crore contract from the Ministry of External Affairs for an Integrated Check Post (ICP) construction project. The project is slated for completion within 59 months. Despite recent declines, RITES' stock has seen an 18% increase over the past year.
Category:
News and Media
Swiggy share price: Swiggy's shares rose 2% after Axis Capital initiated coverage with a 'buy' rating and Rs 640 target, citing strong growth prospects in food delivery and Q-com, with a 20% upside.
Category:
News and Media
All news |
||||||||||||||||||
|